pAAV-Vector-AIO-System-AAV9-CMV-EGFP(CAT#: GTV-0426-YJ12)
This integrated system facilitates the manufacturing of AAV9 vectors. Known for CNS penetration and systemic efficiency, it is an essential tool for treating motor neuron disorders and other genetic diseases affecting muscle and brain using one construct.
| Summary | |
|---|---|
| Application | CNS crossing; Heart & Muscle targeting |
| Related Diseases | Spinal Muscular Atrophy (SMA) |
| System Type | All-in-One System |
| Product Format | Single Plasmid |
| Size | 10 μg; 100 μg; 1 mg; 10 mg |
| AAV Serotype | AAV9 |
| Promoter | CMV |
| Transgene Reporter | EGFP |
| AAV Genome Type | ssAAV |
| Notice to Purchaser | For research use only. Not for use in diagnostic or therapeutic procedures. |
| Spe | |
|---|---|
| ITRs | L-ITR (119 bp) + R-ITR (130 bp) |
| Plasmid Size | 15,161 bp |
| Bacterial Resistance | Kana |
| Storage | Long-term storage: ≤ -20°C (Stable for at least 12 months). |
| Shipping | Dry ice. |
| Synonyms | pAAV-AIO-A9-CMV-EGFP; pAAV-S1-A9-CMV-EGFP; pAIO-AAV9-CMV-EGFP |
